Browsing by Author Brown, Ross D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2010Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapyChen, Yuling; Joshua, Douglas; Li, Jia; Loh, Yen; Sze, Daniel; Yamagishi, Tetsuo; Aklilu, Esther; Brown, Ross D.; Cowley, Mark J.; Ho, P. Joy; Kabani, Karieshma; Kaplan, Warren; Mo, Sulin; Yang, Shihong; Pharmacy; Central Clinical School: Medicine; Chemistry; Pharmacy; Pharmacy; School of Medical Sciences: School of Medical SciencesClonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy, Blood, vol.115, 17,pp 3580-3588
2011Factors influencing the abundance of the side population in a human myeloma cell lineFan, Kei; Joshua, Douglas; Li, Jia; Li, Qian (George); Loh, Yen; Roufogalis, Basil; Smith, Adrian; Sze, Daniel; Brown, Ross D.; Chen, Yuling; Mo, Sui-Lin; Ng, Michelle; Pharmacy; Central Clinical School: Medicine; Chemistry; Pharmacy; Pharmacy; Pharmacy; Medicine; Schl Information TechnologiesFactors influencing the abundance of the side population in a human myeloma cell line, Bone Marrow Research, vol.2011, N/A, 2011,pp 524845-1-524845-8
2011The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationGibson, John; Joshua, Douglas; Brown, Ross D.; Langshaw, M.; Uhr, Elaine J.; Central Clinical School: Medicine; Central Clinical School: MedicineThe impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population, Medical Journal of Australia, vol.194, 2, 2011,pp 65-67
2016Multiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeBryant, Catherine; Gibson, John; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Weatherburn, Claire; Barbaro, P; Brown, Ross D.; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineMultiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade, Leukemia, vol.30, 8, 2016,pp 1716-1724
2016Multiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockadeBryant, Catherine; Gibson, John; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Weatherburn, Claire; Barbaro, P; Brown, Ross D.; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineMultiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade, Leukemia, vol.30, 8, 2016,pp 1716-1724
2003Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopesBasten, Antony; Fazekas De St Groth, Barbara; Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Sze, Daniel; Brown, Ross D.; Yang, Shihong; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; PharmacyPrediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopes, Leukemia & lymphoma, vol.44,(9),2003,pp 1557-1568
2008Presence of Hoechst low side populations in multiple myelomaJoshua, Douglas; Loh, Yen; Roufogalis, Basil; Sze, Daniel; Yamagishi, Tetsuo; Brown, Ross D.; Mo, Sulin; Yang, Shihong; Central Clinical School: Medicine; Pharmacy; Pharmacy; Pharmacy; PharmacyPresence of Hoechst low side populations in multiple myeloma, Leukemia & lymphoma, vol.49,(9),2008,pp 1813-1816
2014Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy productsMacpherson, Janet; Rasko, John; Velickovic, Zlatibor; Brown, Ross D.; Gibson, John; Larsen, Stephen; Wright, Craig; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Concord Clinical School: MedicineRaising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products, Pathology, vol.46, 3, 2014,pp 177-183
2008Rule based processing of the CD4000, CD3200 and CD Sapphire analyser output using the Cerner Discern Expert Module.Gibson, John; Joshua, Douglas; Bell, J.; Brown, Ross D.; Burgess, P.; Coad, C.; Coleman, R.; Estepa, F.; Holman, R.; Hubbard, J.; Huffman, K.; Ibrahim, A.; Johnson, R.; Kershaw, Geoff; Lammers, M.; Langshaw, M.; Lovegrove, J.; Mansy, G.; Pathiraja, R.; Robin, H.; Wick, V.; Xiros, N.; Yuen, S.; Central Clinical School: Medicine; Central Clinical School: MedicineRule based processing of the CD4000, CD3200 and CD Sapphire analyser output using the Cerner Discern Expert Module., International Journal of Laboratory Hematology, vol.31, 6, 2008,pp 603-614
2003T cells in myelomaGibson, John; Joshua, Douglas; Brown, Ross D.; Raitakari, M.; Central Clinical School: Medicine; Central Clinical School: MedicineT cells in myeloma, Hematological Oncology, vol.21,(1),2003,pp 33-42
2010Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.di Pierro, Irene; Handelsman, David; Ip, Flora; Liu, Peter; Brown, Ross D.; Cunningham, Ilona; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteTrough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets., European Journal Of Endocrinology, vol.162, 2,pp 385-390